MarketCap
iRhythm Technologies IRTC
$ 88.65
3.07%
Facebook
X
Telegram
iRhythm Technologies Total Current Liabilities | IRTC
Annual Total Current Liabilities iRhythm Technologies
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 152 M | 111 M | 107 M | 89.1 M | 87.9 M | 65.7 M | 52.1 M | 30.3 M | 20.9 M | 13.2 M | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 152 M | 13.2 M | 72.9 M |
Total Current Liabilities of other stocks in the Medical instruments industry
| Issuer | Total Current Liabilities | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioLife Solutions
BLFS
|
23 M | $ 38.61 | 3.51 % | $ 1.84 B |  USA |
 |
Alcon
ALC
|
1.79 B | $ 72.29 | -2.39 % | $ 35.7 B |  Schweiz |
 |
electroCore
ECOR
|
11.3 M | $ 7.74 | 0.26 % | $ 65.7 M | USA |
 |
Intuitive Surgical
ISRG
|
2.01 B | $ 449.23 | -0.18 % | $ 160 B | USA |
 |
The Cooper Companies
COO
|
1.11 B | $ 62.93 | -1.01 % | $ 12.5 B | USA |
 |
Retractable Technologies
RVP
|
9.6 M | $ 0.55 | 0.04 % | $ 16.5 M | USA |
 |
STERIS plc
STE
|
1.14 B | $ 256.26 | -0.35 % | $ 25.2 B | USA |
 |
Utah Medical Products
UTMD
|
2.6 M | $ 73.41 | 0.75 % | $ 238 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
1.34 B | $ 9.77 | 0.72 % | $ 1.95 B | USA |
 |
InfuSystem Holdings
INFU
|
20.2 M | $ 15.0 | -1.83 % | $ 310 M | USA |
 |
OraSure Technologies
OSUR
|
39.8 M | $ 3.55 | 6.61 % | $ 261 M | USA |
 |
Atrion Corporation
ATRI
|
12.6 K | - | - | $ 810 M | USA |
 |
STAAR Surgical Company
STAA
|
68.5 M | $ 26.41 | 10.64 % | $ 1.31 B | USA |
 |
NeuroMetrix
NURO
|
1.01 M | - | 5.05 % | $ 9.02 M | USA |
 |
Teleflex Incorporated
TFX
|
762 M | $ 155.91 | 0.55 % | $ 6.96 B | USA |
 |
Becton, Dickinson and Company
BDX
|
8.31 B | $ 213.53 | 0.4 % | $ 61.4 B | USA |
 |
West Pharmaceutical Services
WST
|
655 M | $ 413.04 | 0.12 % | $ 29.9 B | USA |
 |
Baxter International
BAX
|
2.97 B | $ 26.37 | -0.15 % | $ 13.5 B | USA |
 |
Repro Med Systems
KRMD
|
8.19 M | $ 3.73 | 17.88 % | $ 172 M | USA |
 |
AtriCure
ATRC
|
81.5 M | $ 57.54 | 2.28 % | $ 2.75 B | USA |
 |
AngioDynamics
ANGO
|
74.7 M | $ 12.41 | 2.82 % | $ 515 M | USA |
 |
Glaukos Corporation
GKOS
|
101 M | $ 246.34 | 4.15 % | $ 14.1 B | USA |
 |
Harvard Bioscience
HBIO
|
22 M | $ 9.81 | 5.94 % | $ 435 M | USA |
 |
CRH Medical Corporation
CRHM
|
11.8 M | - | - | $ 282 M | USA |
 |
Microbot Medical
MBOT
|
3.42 M | $ 1.11 | 5.71 % | $ 50.8 M |  Israel |
 |
Haemonetics Corporation
HAE
|
283 M | $ 120.49 | -1.58 % | $ 5.68 B | USA |
 |
Cantel Medical Corp.
CMD
|
179 M | - | -1.18 % | $ 3.4 B | USA |
 |
ICU Medical
ICUI
|
499 M | $ 178.32 | -2.15 % | $ 4.39 B | USA |
 |
ResMed
RMD
|
1.4 B | $ 238.38 | 1.81 % | $ 34.7 B | USA |
 |
Milestone Scientific
MLSS
|
4.13 M | $ 0.31 | 1.7 % | $ 25.4 M | USA |
 |
Merit Medical Systems
MMSI
|
240 M | $ 88.19 | 0.43 % | $ 5.22 B | USA |
 |
Nephros
NEPH
|
2.77 M | $ 3.09 | -2.06 % | $ 32.8 M | USA |
 |
Pro-Dex
PDEX
|
13 M | $ 71.2 | 1.92 % | $ 230 B | USA |
 |
Envista Holdings Corporation
NVST
|
853 M | $ 25.33 | -1.99 % | $ 4.26 B | USA |
 |
LeMaitre Vascular
LMAT
|
36.3 M | $ 79.26 | 0.3 % | $ 1.79 B | USA |
 |
Pulse Biosciences
PLSE
|
7.92 M | $ 56.65 | 2.77 % | $ 3.82 B | USA |
 |
Repligen Corporation
RGEN
|
136 M | $ 172.96 | -0.59 % | $ 9.73 B | USA |
 |
Luminex Corporation
LMNX
|
87.5 M | - | - | $ 1.75 B | USA |
 |
Akers Biosciences, Inc.
AKER
|
1.53 M | - | -9.52 % | $ 20.6 M | USA |
 |
Antares Pharma, Inc.
ATRS
|
63.2 M | - | - | $ 955 M | USA |
 |
Hill-Rom Holdings, Inc.
HRC
|
952 M | - | -0.05 % | $ 10.3 B | USA |
 |
Varian Medical Systems, Inc.
VAR
|
1.85 B | - | -0.02 % | $ 16.3 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
86.9 M | - | - | $ 28.6 M | USA |
 |
Isoray
ISR
|
28.7 M | - | 0.03 % | $ 108 M | USA |
 |
Masimo Corporation
MASI
|
618 M | - | - | $ 9.59 B | USA |
 |
Stereotaxis
STXS
|
22.4 M | $ 0.9 | -12.63 % | $ 81.9 M | USA |
 |
Predictive Oncology
POAI
|
4.27 M | - | - | $ 31.1 M | USA |